Action observation for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Stroke
Action observation - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will help researchers understand if a therapy called action observation, which involves watching and replicating normal arm and hand movements, can help stroke survivors learn how to use their arm and hand again.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Eye gaze recorded in one day during the 3 blocks of video watching (action observation)

Arm and hand movement recorded in one day during the 3 blocks of physical performance of the SRTT
Arm and hand movement with the Serial Reaction Time Test (SRTT)
Eye gaze recorded in one day during the 3 blocks of video watching (action observation)
Eye gaze pattern

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Action observation
1 of 1
Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Action observation · No Placebo Group · N/A

Action observation
Behavioral
Experimental Group · 1 Intervention: Action observation · Intervention Types: Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Action observation
2020
N/A
~210

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: eye gaze recorded in one day during the 3 blocks of video watching (action observation)

Who is running the clinical trial?

Georgia Institute of TechnologyOTHER
43 Previous Clinical Trials
4,444 Total Patients Enrolled
3 Trials studying Stroke
44 Patients Enrolled for Stroke
Georgia State UniversityLead Sponsor
49 Previous Clinical Trials
22,461 Total Patients Enrolled
1 Trials studying Stroke
116 Patients Enrolled for Stroke
Veronica T Rowe, PhD, OTR/LPrincipal InvestigatorGeorgia State University

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 8th, 2021

Last Reviewed: October 20th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Massachusetts50.0%
Georgia50.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Georgia Tech100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria50.0%
Met criteria50.0%

How responsive is this trial?

Typically responds via
Email100.0%